Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Vanguard Study Group
Affiliation not provided to SSRN
SCHOLARLY PAPERS
1
DOWNLOADS
55
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Early Treatment With Nitazoxanide Prevents Worsening of Mild and Moderate COVID-19 and Subsequent Hospitalization
Number of pages: 19
Posted: 06 Oct 2021
Jean-Francois Rossignol
,
Matthew Bardin
,
Matthew Bardin
,
Jessica Fulgencio
,
Jessica Fulgencio
,
Dena Mogelnicki
,
Dena Mogelnicki
,
Christian Brechot
and Vanguard Study Group
Romark Laboratories, L.C. - Romark Institute of Medical Research,
affiliation not provided to SSRN
Romark Laboratories, L.C. - Romark Institute of Medical Research,
affiliation not provided to SSRN
Romark Laboratories, L.C. - Romark Institute of Medical Research,
affiliation not provided to SSRN
Romark Laboratories, L.C. - Romark Institute of Medical Research, University of South Florida - College of Medicine and
affiliation not provided to SSRN
Downloads
55
(1,020,567)
Citation
1
View PDF
Download
Abstract:
Covid-19, Nitazoxanide, Respiratory Infection, Antiviral, SARS-CoV-2
Feedback
